INTELLIA THERAPEUTICS, INC. Increase (Decrease) in Other Operating Assets
INTELLIA THERAPEUTICS, INC. (NTLA) reported Increase (Decrease) in Other Operating Assets of -$538.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingAssets · last filed 2026-08-06
- INTELLIA THERAPEUTICS, INC. increase (decrease) in other operating assets for the quarter ending 2026-06-30 was -$612.00K, a 105.78% decline year-over-year.
- INTELLIA THERAPEUTICS, INC. increase (decrease) in other operating assets for the quarter ending 2026-03-31 was $74.00K, a 99.46% decline year-over-year.
- INTELLIA THERAPEUTICS, INC. increase (decrease) in other operating assets for the quarter ending 2025-12-31 was -$1.94M, a 446.69% decline year-over-year.
- INTELLIA THERAPEUTICS, INC. increase (decrease) in other operating assets for the quarter ending 2025-09-30 was -$25.29M, a 148852.94% decline year-over-year.
- INTELLIA THERAPEUTICS, INC. increase (decrease) in other operating assets for fiscal 2025 was -$2.81M.
- INTELLIA THERAPEUTICS, INC. increase (decrease) in other operating assets for fiscal 2024 was -$917.00K, a 229.70% decline from fiscal 2023.
- INTELLIA THERAPEUTICS, INC. increase (decrease) in other operating assets for fiscal 2023 was $707.00K, a 35.20% decline from fiscal 2022.
- INTELLIA THERAPEUTICS, INC. increase (decrease) in other operating assets for fiscal 2022 was $1.09M.
| Period end | Increase (Decrease) in Other Operating Assets 3 month | Increase (Decrease) in Other Operating Assets 6 month | Increase (Decrease) in Other Operating Assets 8 month | Increase (Decrease) in Other Operating Assets 9 month | Increase (Decrease) in Other Operating Assets 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | -$612.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$538.00K 10-Q · filed 2026-08-06 | -$2.48M derived: sum of 3 quarters · filed 2026-08-06 | -$27.76M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $74.00K 10-Q · filed 2026-05-11 | -$1.86M derived: sum of 2 quarters · filed 2026-05-11 | -$27.15M derived: sum of 3 quarters · filed 2026-05-11 | -$16.56M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | -$1.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$27.23M derived: sum of 2 quarters · filed 2026-02-26 | -$16.64M derived: sum of 3 quarters · filed 2026-08-06 | -$2.81M 10-K · filed 2026-02-26 | |
| 2025-09-30 | -$25.29M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$14.70M derived: sum of 2 quarters · filed 2026-08-06 | -$873.00K 10-Q · filed 2025-11-06 | -$314.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | $10.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $24.41M 10-Q · filed 2026-08-06 | $24.97M derived: sum of 3 quarters · filed 2026-08-06 | $24.99M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | $13.83M 10-Q · filed 2026-05-11 | $14.38M derived: sum of 2 quarters · filed 2026-05-11 | $14.40M derived: sum of 3 quarters · filed 2026-05-11 | $13.63M derived: sum of 4 quarters · filed 2026-05-11 | |
| 2024-12-31 | $559.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $576.00K derived: sum of 2 quarters · filed 2026-02-26 | -$193.00K derived: sum of 3 quarters · filed 2026-02-26 | -$917.00K 10-K · filed 2026-02-26 | |
| 2024-09-30 | $17.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$752.00K derived: sum of 2 quarters · filed 2025-11-06 | -$1.48M 10-Q · filed 2025-11-06 | -$1.60M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | -$769.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$1.49M 10-Q · filed 2025-08-07 | -$1.62M derived: sum of 3 quarters · filed 2026-02-26 | -$1.29M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | -$724.00K 10-Q · filed 2025-05-08 | -$853.00K derived: sum of 2 quarters · filed 2026-02-26 | -$520.00K derived: sum of 3 quarters · filed 2026-02-26 | -$410.00K derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | -$129.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $204.00K derived: sum of 2 quarters · filed 2026-02-26 | $314.00K derived: sum of 3 quarters · filed 2026-02-26 | $707.00K 10-K · filed 2026-02-26 | |
| 2023-09-30 | $333.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $443.00K derived: sum of 2 quarters · filed 2024-11-07 | $836.00K 10-Q · filed 2024-11-07 | $945.00K derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-06-30 | $110.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $503.00K 10-Q · filed 2024-08-08 | $612.00K derived: sum of 3 quarters · filed 2025-02-27 | $792.00K derived: sum of 4 quarters · filed 2025-02-27 | |
| 2023-03-31 | $393.00K 10-Q · filed 2024-05-09 | $502.00K derived: sum of 2 quarters · filed 2025-02-27 | $682.00K derived: sum of 3 quarters · filed 2025-02-27 | $566.00K derived: sum of 4 quarters · filed 2025-02-27 | |
| 2022-12-31 | $109.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $289.00K derived: sum of 2 quarters · filed 2025-02-27 | $173.00K derived: sum of 3 quarters · filed 2025-02-27 | $1.09M 10-K · filed 2025-02-27 | |
| 2022-09-30 | $180.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $64.00K derived: sum of 2 quarters · filed 2023-11-09 | $982.00K 10-Q · filed 2023-11-09 | $617.00K derived: sum of 4 quarters · filed 2024-02-22 | |
| 2022-06-30 | -$116.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $802.00K 10-Q · filed 2023-08-03 | $437.00K derived: sum of 3 quarters · filed 2024-02-22 | $456.00K derived: sum of 4 quarters · filed 2024-02-22 | |
| 2022-03-31 | $918.00K 10-Q · filed 2023-05-04 | $553.00K derived: sum of 2 quarters · filed 2024-02-22 | $572.00K derived: sum of 3 quarters · filed 2024-02-22 | $546.00K derived: sum of 4 quarters · filed 2024-02-22 | |
| 2021-12-31 | -$365.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$346.00K derived: sum of 2 quarters · filed 2024-02-22 | -$372.00K derived: sum of 3 quarters · filed 2024-02-22 | -$117.00K 10-K · filed 2024-02-22 | |
| 2021-09-30 | $19.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | -$7.00K derived: sum of 2 quarters · filed 2022-11-03 | $248.00K 10-Q · filed 2022-11-03 | $513.00K derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-06-30 | -$26.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $229.00K 10-Q · filed 2022-08-04 | $494.00K derived: sum of 3 quarters · filed 2023-02-23 | $385.00K derived: sum of 4 quarters · filed 2023-02-23 | |
| 2021-03-31 | $255.00K 10-Q · filed 2022-05-05 | $520.00K derived: sum of 2 quarters · filed 2023-02-23 | $411.00K derived: sum of 3 quarters · filed 2023-02-23 | $269.00K derived: sum of 4 quarters · filed 2023-02-23 | |
| 2020-12-31 | $265.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $156.00K derived: sum of 2 quarters · filed 2023-02-23 | $14.00K derived: sum of 3 quarters · filed 2023-02-23 | -$83.00K 10-K · filed 2023-02-23 | |
| 2020-09-30 | -$109.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | -$251.00K derived: sum of 2 quarters · filed 2021-11-04 | -$348.00K 10-Q · filed 2021-11-04 | -$391.00K derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-06-30 | -$142.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$239.00K 10-Q · filed 2021-08-05 | -$282.00K derived: sum of 3 quarters · filed 2022-02-24 | -$267.00K derived: sum of 4 quarters · filed 2022-02-24 | |
| 2020-03-31 | -$97.00K 10-Q · filed 2021-05-06 | -$140.00K derived: sum of 2 quarters · filed 2022-02-24 | -$125.00K derived: sum of 3 quarters · filed 2022-02-24 | -$166.00K derived: sum of 4 quarters · filed 2022-02-24 | |
| 2019-12-31 | -$43.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$28.00K derived: sum of 2 quarters · filed 2022-02-24 | -$69.00K derived: sum of 3 quarters · filed 2022-02-24 | -$153.00K 10-K · filed 2022-02-24 | |
| 2019-09-30 | $15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | -$26.00K derived: sum of 2 quarters · filed 2020-11-05 | -$110.00K 10-Q · filed 2020-11-05 | -$468.00K derived: sum of 4 quarters · filed 2021-02-26 | |
| 2019-06-30 | -$41.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | -$125.00K 10-Q · filed 2020-08-06 | -$483.00K derived: sum of 3 quarters · filed 2021-02-26 | -$583.00K derived: sum of 4 quarters · filed 2021-02-26 | |
| 2019-03-31 | -$84.00K 10-Q · filed 2020-05-07 | -$442.00K derived: sum of 2 quarters · filed 2021-02-26 | -$542.00K derived: sum of 3 quarters · filed 2021-02-26 | -$788.00K derived: sum of 4 quarters · filed 2021-02-26 | |
| 2018-12-31 | -$358.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | -$458.00K derived: sum of 2 quarters · filed 2021-02-26 | -$704.00K derived: sum of 3 quarters · filed 2021-02-26 | -$1.02M 10-K · filed 2021-02-26 | |
| 2018-09-30 | -$100.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | -$346.00K derived: sum of 2 quarters · filed 2019-10-31 | -$664.00K 10-Q · filed 2019-10-31 | -$1.09M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-06-30 | -$246.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$564.00K 10-Q · filed 2019-08-01 | -$988.00K derived: sum of 3 quarters · filed 2020-02-27 | -$909.00K derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-03-31 | -$318.00K 10-Q · filed 2019-05-02 | -$742.00K derived: sum of 2 quarters · filed 2020-02-27 | -$663.00K derived: sum of 3 quarters · filed 2020-02-27 | -$952.00K derived: sum of 4 quarters · filed 2020-02-27 | |
| 2017-12-31 | -$424.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | -$345.00K derived: sum of 2 quarters · filed 2020-02-27 | -$634.00K derived: sum of 3 quarters · filed 2020-02-27 | -$902.00K 10-K · filed 2020-02-27 | |
| 2017-09-30 | $79.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | -$210.00K derived: sum of 2 quarters · filed 2018-10-31 | -$478.00K 10-Q · filed 2018-10-31 | $3.28M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2017-06-30 | -$289.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | -$557.00K 10-Q · filed 2018-08-01 | $3.20M derived: sum of 3 quarters · filed 2019-02-27 | $3.18M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2017-03-31 | -$268.00K 10-Q · filed 2018-05-01 | $3.49M derived: sum of 2 quarters · filed 2019-02-27 | $3.47M derived: sum of 3 quarters · filed 2019-02-27 | $3.34M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2016-12-31 | $3.76M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $3.74M derived: sum of 2 quarters · filed 2019-02-27 | $3.61M derived: sum of 3 quarters · filed 2019-02-27 | $6.43M 10-K · filed 2019-02-27 | |
| 2016-09-30 | -$24.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-31 | -$148.00K derived: sum of 2 quarters · filed 2017-10-31 | $2.67M 10-Q · filed 2017-10-31 | $1.91M derived: sum of 4 quarters · filed 2018-03-14 | |
| 2016-06-30 | -$124.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-01 | $2.70M 10-Q · filed 2017-08-01 | $1.93M derived: sum of 3 quarters · filed 2018-03-14 | $2.74M derived: sum of 4 quarters · filed 2018-03-14 | |
| 2016-03-31 | $2.82M 10-Q · filed 2017-05-02 | $2.06M derived: sum of 2 quarters · filed 2018-03-14 | $2.87M derived: sum of 3 quarters · filed 2018-03-14 | ||
| 2015-12-31 | -$765.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-14 | $45.00K derived: sum of 2 quarters · filed 2018-03-14 | $76.00K 10-K · filed 2018-03-14 | ||
| 2015-09-30 | $810.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01 | $841.00K 10-Q · filed 2016-11-01 | |||
| 2015-06-30 | $31.00K 10-Q · filed 2016-08-04 | ||||
| 2014-12-31 | $256.00K 10-K · filed 2017-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |